| Financial Year |
March 31 2023 |
| Monetary Funds |
3,852,918,021.33 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,530,625.51 |
| Accounts Receivable |
2,244,557,575.90 |
| Advances to Suppliers |
34,571,826.03 |
| Other Receivables |
16,699,727.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,884,746,829.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
943,910,410.28 |
| Other Current Assets |
58,236,398.07 |
| Total Current Assets |
9,077,107,572.80 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
726,209,729.57 |
| Long-term Equity Investment |
119,247,575.60 |
| Investment Properties |
-- |
| Fixed Assetes |
944,635,599.89 |
| Under-construction Projects |
640,947,117.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
392,765,476.94 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,283,938.77 |
| Deferred Income Tax Assets |
32,072,918.96 |
| Other Non-Current Assets |
70,523,200.00 |
| Sub-Total of Non-Current Assets |
3,202,347,131.23 |
| Total Assets |
12,279,454,704.03 |
| Short-Term Loans |
340,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,357,300,341.99 |
| Accounts Payable |
1,113,036,158.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
35,997,112.88 |
| Taxes Payable |
151,574,246.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
243,745,970.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
543,701,610.11 |
| Other Current Liabilities |
13,916,271.32 |
| Sub-Total of Current Liabilities |
3,917,057,209.17 |
| Long-term Loans |
722,405,685.77 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
76,124,837.40 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
978,354,007.51 |
| Total Liabilities |
4,895,411,216.68 |
| Paid-In Capital(Or Share Stock) |
506,347,879.00 |
| Capital Surplus |
2,367,784,898.94 |
| Surplus Reserve |
261,714,343.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,240,919,813.90 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,384,043,487.35 |
| Owner's Equity（Stockholder's Equity） |
7,384,043,487.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,279,454,704.03 |
